Thymosin Beta-4 for Nerve Damage
Research, mechanism, dosing, and effectiveness of Thymosin Beta-4 for nerve damage.
Quick Answer
TB4 may support nerve regeneration.
Evidence Level
Human Trials
Typical Dose
2-5 mg weekly
Results Timeline
Nerve healing over 4-12 weeks
FDA Status
Research Only
How Thymosin Beta-4 Works for Nerve Damage
Promotes cell migration and tissue repair.
About Nerve Damage
Support for nerve repair and regeneration.
Research Evidence
Extensive research on wound healing, cardiac repair, and tissue regeneration. Studies show TB-4 accelerates dermal wound closure and promotes corneal epithelial healing. Research in cardiac repair shows improved outcomes post-myocardial infarction in animal models. The shorter half-life means more frequent dosing compared to TB-500.
Dosing for Nerve Damage
Recommended Dose
2-5 mg weekly
Frequency
2-3x weekly
Administration
Subcutaneous injection, topical for eye conditions
Duration
4-8 weeks typical protocol
Note: Full 43-amino acid protein (not TB-500 fragment). Similar uses but shorter half-life. Often confused with TB-500 in marketplace.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated
- •Injection site reactions
- •Headache
- •Fatigue
- •May trigger histamine release - use caution with MCAS or histamine sensitivity
- •Theoretical concern for cancer cell motility
Frequently Asked Questions
Does Thymosin Beta-4 help with nerve damage?
TB4 may support nerve regeneration.
How does Thymosin Beta-4 work for nerve damage?
Promotes cell migration and tissue repair....
What dose of Thymosin Beta-4 should I use for nerve damage?
2-5 mg weekly
How long until I see results?
Nerve healing over 4-12 weeks
Other Peptides for Nerve Damage
These peptides are also researched for nerve damage.
TB-500
PreclinicalA synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.
BPC-157
PreclinicalA synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems. FDA classified as Category 2 in 2023, restricting compounding.
Pentadecapeptide
PreclinicalThe full 15-amino acid sequence that includes BPC-157. While BPC-157 is more commonly discussed, the full pentadecapeptide has similar healing properties derived from gastric juice.
Ziconotide
FDAA synthetic cone snail venom peptide for severe chronic pain. The first intrathecal non-opioid analgesic FDA approved.
Educational Information Only
This information about Thymosin Beta-4 for nerve damage is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.